Oncology Aligning with national efforts to modernise cancer diagnosti... Andrew Newland, former CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.
Patients Rethinking prescription drug affordability, with Vinay Patel Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.
Digital An AI supercomputer and discovering next-gen brain disorder ... Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.
R&D On genomics, NGS, and doing much more good than bad, with Ma... Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Digital AI for the planet, AI for life sciences – with Patrick Leung Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
